PD-0420: Induction by mFOLFIRINOX followed by SIBSBRT for the neoadjuvant treatment of pancreatic cancer. (November 2020) - Bouchart, C.; Engelholm, J.; Bali, M.A.; Closset, J.; Navez, J.; Loi, P.; Gökburun, Y.; De Grez, T.; Hendlisz, A.; Mans, L.; Eisendrath, P.; Van Gestel, D.; et al.